CHRONIC KIDNEY DISEASE: AN AYURVEDIC PERSPECTIVE THROUGH THE LENS OF KAYACHIKITSA

Chronic kidney disease (CKD) represents a progressive loss of renal function over time and poses significant challenges in global healthcare. In Ayurveda, CKD is understood as an Upadrava (complication) of urinary system disorders or systemic conditions such as Prameha (diabetes). This review explores the Ayurvedic perspective on CKD, focusing on its pathogenesis, prognosis, and therapeutic approaches. The disease is characterized by the vitiation of Dosha and their impact on Basti (renal system), leading to impaired filtration and systemic toxicity. Early stages are considered Krucchrasadhya (difficult to treat), whereas advanced stages are Yapya (manageable with palliation) or incurable. Management strategies in Ayurveda emphasize purification (Shodhana), pacification (Shamana), and rejuvenation (Rasayana) therapies. Detoxification procedures like Virechana and Basti therapy are employed to eliminate vitiated Dosha and restore systemic balance. Rasayana drugs such as Punarnava, Gokshura, and Shilajit enhance renal function, act as antioxidants, and provide nephroprotective effects. Clinical studies indicate improvements in digestion, vitality, and quality of life with these interventions. The integration of Ayurvedic principles, including dietary and lifestyle modifications, offers a holistic approach to CKD, addressing its systemic effects and slowing disease progression. This study underscores the potential of Ayurveda as a complementary and cost-effective therapeutic framework for CKD, particularly in resource-limited settings, by reducing reliance on conventional renal replacement therapies and improving patient outcomes.

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-09-01
DOI
https://doi.org/10.5281/zenodo.22159618
Primary Topic
Humic Substances and Bio-Organic Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
article

CHRONIC KIDNEY DISEASE: AN AYURVEDIC PERSPECTIVE THROUGH THE LENS OF KAYACHIKITSA

2Dr. Subhash Babu N. 1*Dr. Arpita Gupta
Zenodo (CERN European Organization for Nuclear Research)
Humic Substances and Bio-Organic Studies
article

CHRONIC KIDNEY DISEASE: AN AYURVEDIC PERSPECTIVE THROUGH THE LENS OF KAYACHIKITSA

2Dr. Subhash Babu N. 1*Dr. Arpita Gupta
article en

Abstract

Chronic kidney disease (CKD) represents a progressive loss of renal function over time and poses significant challenges in global healthcare. In Ayurveda, CKD is understood as an Upadrava (complication) of urinary system disorders or systemic conditions such as Prameha (diabetes). This review explores the Ayurvedic perspective on CKD, focusing on its pathogenesis, prognosis, and therapeutic approaches. The disease is characterized by the vitiation of Dosha and their impact on Basti (renal system), leading to impaired filtration and systemic toxicity. Early stages are considered Krucchrasadhya (difficult to treat), whereas advanced stages are Yapya (manageable with palliation) or incurable. Management strategies in Ayurveda emphasize purification (Shodhana), pacification (Shamana), and rejuvenation (Rasayana) therapies. Detoxification procedures like Virechana and Basti therapy are employed to eliminate vitiated Dosha and restore systemic balance. Rasayana drugs such as Punarnava, Gokshura, and Shilajit enhance renal function, act as antioxidants, and provide nephroprotective effects. Clinical studies indicate improvements in digestion, vitality, and quality of life with these interventions. The integration of Ayurvedic principles, including dietary and lifestyle modifications, offers a holistic approach to CKD, addressing its systemic effects and slowing disease progression. This study underscores the potential of Ayurveda as a complementary and cost-effective therapeutic framework for CKD, particularly in resource-limited settings, by reducing reliance on conventional renal replacement therapies and improving patient outcomes.

Zenodo (CERN European Organization for Nuclear Research)
Openalex Percentile: Top 12%
Humic Substances and Bio-Organic Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

CHRONIC KIDNEY DISEASE: AN AYURVEDIC PERSPECTIVE THROUGH THE LENS OF KAYACHIKITSA — 2Dr. Subhash Babu N. 1*Dr. Arpita Gupta · Zenodo (CERN European Organization for Nuclear Research) (2026) | TGRS Research Map | TGRS